[Histonet] Questions RE: "what I have found about p16" and cellblocks for controls

Cassie P. Davis CDavis at che-east.org
Fri Jan 6 11:25:40 CST 2017



Is there anyone in Histonet land who is using both the Optiview and Ultraview on the XT and ULTRA at the same time? I'd like to ask a few questions, please email me.



We have a cytology cellblock case that came out stunningly positive for Her2 and one of our pathologist thought it would make a dynamic control if there were any specimen left to make the control block.

While I am excited about the possiblity (Her2 control is hard to come by around here) some concern is expressed about using it because it is initally fixed in cytolyt before FFPE. I can argue both sides of this. I would enjoy your input on this folks.


Cassandra Davis
Histology Technician
AP Laboratory
302-575-8095
Email:  CDavis at che-east.org<mailto:CDavis at che-east.org>


________________________________
From: Cassie P. Davis
Sent: Thursday, January 05, 2017 10:02 AM
To: histonet at lists.utsouthwestern.edu
Subject: what I have found about p16


Hi Histonet folks,

             Thank you for all the help, for those who are following what I have found:

(1)



Sigma-Aldrich does have p16 (it is also know as INKa):



Anti-INKa(p16) antibody, clone 13H4.1   cat # MABE1328

or

Anti-p16 Antibody, clone D25  cat#MAB4133



(2)



Stacy was kind enough to share this:





Hi Cassie,
Are you referring to Ventana?
If so, they will have 2 other kits coming out for it.  They will require the use of Optiview detection or it will be considered an LDT.  Just found this out from my rep.
Thanks,
Stacy

Stacy McLaughlin, HT (ASCP)
Histology Supervisor
Cooley Dickinson Healthcare
30 Locust Street
Northampton, MA 01060
(413-582-2019



****Stacy, thanks for sharing! We did not get that information from our rep.


Cassandra Davis
Histology Technician
AP Laboratory
302-575-8095
Email:  CDavis at che-east.org<mailto:CDavis at che-east.org>


Confidentiality Notice:
This e-mail, including any attachments is the property of Trinity Health and is intended for the sole use of the intended recipient(s). It may contain information that is privileged and confidential.  Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not the intended recipient, please delete this message, and reply to the sender regarding the error in a separate email.


More information about the Histonet mailing list